About one in four Indian adults with type 2 diabetes had sarcopenia, with very wide uncertainty

Design

Systematic review and meta-analysis of cross-sectional studies

Population

7 studies, 1,359 Indian adults with type 2 diabetes

Primary outcome

Prevalence of sarcopenia by Asian Working Group criteria

Effect

27.4% (95% CI 18.9 to 37.9); prediction interval 6.9% to 65.6%; certainty very low

This systematic review pooled seven cross-sectional Indian studies (1,359 adults with type 2 diabetes) that used Asian Working Group for Sarcopenia criteria.

Confirmed sarcopenia was estimated at 27.4% (95% CI 18.9% to 37.9%), severe sarcopenia at 11.0% and sarcopenic obesity at 25.2%. Heterogeneity was very high (I-squared 92%), and the prediction interval for a new population ran from 6.9% to 65.6%. Estimates were lower when muscle mass was measured by DEXA (20.2%) than by bioimpedance (31.7%). Hypertension and diabetes duration of ten years or more were linked to sarcopenia in the two studies that adjusted for confounders. The authors rated certainty very low and said this is not yet a basis for a screening programme.

For clinicians, the message is awareness rather than a new test. Grip strength and a chair-stand test take two minutes and pick up the patients whose diabetes care should include resistance exercise and adequate protein, particularly older patients and those losing weight on glucose-lowering drugs.

• Check grip strength or a five-times chair-stand test in older adults with type 2 diabetes who report weakness, falls or weight loss.
• Advise resistance exercise as part of diabetes care, not only walking.
• Review protein intake, especially in patients losing weight on glucose-lowering treatment.
• Be aware that bioimpedance may give higher sarcopenia estimates than DEXA.
• Do not start systematic sarcopenia screening on the basis of this review alone.

Why it matters

Diabetes care in India focuses on glucose; muscle loss that drives falls and disability is often not looked for.

Don't overread it

With seven small studies and very high heterogeneity, the true prevalence could be anywhere from about 7% to 66%.

The statistics, in plain English

The prediction interval (7% to 66%) shows where the prevalence in a new Indian clinic might fall, and it is very wide. I-squared of 92% means most of the variation between studies reflects real differences in populations and methods, not chance.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.